About the survey
The scientific survey is being conducted to evaluate the physicians’
perspective on the use of adjuvant therapy with antioxidants in patients with neurodegenerative
disorders.
This survey can help to derive opinions from well-known HCP's
regarding the use of antioxidants as adjuvant treatment in age-related neurodegenerative
diseases and patients with stroke and ischemic brain injury. It can also assist in deriving an
unbiased approach in selecting the therapeutic regimen in the best interest of the patient.
Objectives:
1. To derive an unbiased approach in decision-making regarding co-prescription of antioxidants
with standard treatment regimen in neurodegenerative disorders.
2. To collect thoughts, opinions, and comments from the desired reputed targeted doctors. The
valuable feedback derived shall serve as a baseline to measure and establish a new horizon as
well as compare results over time.
3. To derive results related to the safety, efficacy, and improvement in the quality of life of
patients with the use of L-carnosine + ALA + CoQ10 combination as adjuvant treatment.